• S&P 500: 1,342.64
  • Change: -0.69%
$9.43 -0.13 (-1.36%)
2/10/2012 4:00 PM

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 3 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Current Price $9.43 Mkt Cap $671.64M
Open $9.44 P/E Ratio 0.00
Prev. Close $9.56 Div. (Yield) N/A (N/A)
Daily Range $9.31 - $9.59 Volume 157,068
52-Wk Range $6.42 - $10.60 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think RIGL will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

136 Outperform
53 Underperform
 

All-Star Players

43 Outperform
18 Underperform
 

Wall Street

8 Outperform
1 Underperform
 

Top RIGL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.27)
Submitted November 17, 2010

Rigel is a company I always keep my eye on when the share price is low, because of the explosion in their share price that occurred in late 2007 with encouraging phase II data for their RA drug R788, now known as fostamatinib. Since then, the… More

Add Comment | Reply | Report this Post

ScreenerStizBear (< 20)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

1 Comment | Reply | Report this Post
RIGL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about RIGL.

Recs

0
Member Avatar Fiskhus (76.48) Submitted: 5/17/2011 12:34:05 AM : Outperform Start Price: $8.06 RIGL Score: +15.74

MB9A

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar gravmic (< 20) Submitted: 5/16/2011 3:35:28 PM : Outperform Start Price: $8.06 RIGL Score: +16.19

magic formula

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar medsmall (< 20) Submitted: 4/4/2011 11:38:08 PM : Outperform Start Price: $7.20 RIGL Score: +29.95

Price/earnings of 10.04, Price/book of 2.26, Debt/equity ratio of zero, Return on Invested Capital (TTM) of 27.19, clinical-stage drug development company based in California, United States.

Report this Post Add Comment | Reply | Permalink
View All 25 Pitches »

Leaderboard

Find the members with the highest scoring picks in RIGL.

Score Leader

fluxxdeluxx

fluxxdeluxx (< 20) Score: +136.18

The Score Leader is the player with the highest score across all their picks in RIGL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
schwah8 98.60 10/13/2008 Underperform NS $18.26 -48.36% +45.91% +94.27 0 Comment
cybob2000 32.55 10/23/2008 Underperform 3W $15.64 -39.71% +52.67% +92.38 0 Comment
seanchile 98.26 1/18/2008 Underperform 3Y $28.03 -66.36% +3.92% +70.28 0 Comment
darksider389 63.87 7/7/2008 Underperform 3M $21.97 -57.08% +11.35% +68.43 0 Comment
chilejohn 67.25 1/28/2008 2/26/2011 Underperform 1Y $25.55 -63.09% +5.08% +68.17 0 Comment
duchey 93.78 1/28/2008 Underperform 1Y $25.55 -63.09% +5.08% +68.17 0 Comment
flats66 39.36 8/14/2008 9/18/2009 Underperform 3Y $22.71 -58.48% +8.42% +66.89 0 Comment
ScreenerStizBear < 20 6/26/2008 Underperform NS $22.85 -58.73% +7.46% +66.19 2 Comments
eXigy 90.22 2/4/2008 Underperform NS $26.62 -64.58% +1.02% +65.60 0 Comment
supershark 83.17 1/15/2008 Underperform 3Y $26.32 -64.17% +0.17% +64.34 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJimCramer 78.17 12/1/2011 Underperform 3W $7.52 +25.40% +7.51% -17.88 0 Comment
TrackJGreenblatt 85.34 4/25/2011 Outperform 1Y $7.82 +20.59% +0.51% +20.08 1 Comment
TrackPiperJaff 89.09 3/12/2010 Outperform NS $8.01 +17.73% +15.88% +1.85 0 Comment
TrackRBCCapMkts 93.36 11/24/2009 Outperform NS $8.16 -1.35% -4.38% +3.03 8/24/2010 @ $8.05 0 Comment
TrackRodmanRen < 20 6/9/2009 Outperform NS $10.07 -6.36% +43.73% -50.09 0 Comment
TrackRBCCapMkts 93.36 1/30/2009 Underperform NS $6.80 +20.00% +30.95% +10.95 11/23/2009 @ $8.16 0 Comment
TrackOppenheimer 79.13 12/1/2008 Outperform NS $7.22 +30.61% +57.53% -26.92 0 Comment
TrackRBCCapMkts 93.36 9/3/2008 Outperform NS $23.35 -62.87% -31.71% -31.16 10/28/2008 @ $8.67 0 Comment
TrackCitigroup 93.21 8/27/2008 Outperform NS $22.40 -58.21% -23.67% -34.55 7/24/2009 @ $9.36 0 Comment
TrackStanfordRes 85.38 7/22/2008 Outperform NS $24.58 -61.64% +10.78% -72.42 0 Comment
TrackFortisBank < 20 1/7/2008 Outperform NS $24.19 -9.01% -24.30% +15.29 10/2/2008 @ $22.01 0 Comment
TrackLehmanBros 86.48 12/14/2007 Outperform NS $27.33 -65.50% -4.84% -60.66 0 Comment
TrackCreditSuiss 92.69 7/19/2007 Outperform NS $8.76 +7.65% -8.87% +16.52 0 Comment
TrackJefferies 84.73 6/8/2007 Outperform NS $9.50 -0.74% -4.99% +4.25 0 Comment

Featured Broker Partners